CareDx Inc.
Organization details
- Legal name
- CareDx Inc.
- Former names
- XDx, Inc. Expression Diagnostics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Brisbane
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CDNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001217234
- EIN
- 94-3316839
- Wikidata ID
- Q106238469
Board of directors
-
Arthur A. Torres · DirectorSince 2023
-
Christine Cournoyer · DirectorSince 2023
- Since 2023
-
George Bickerstaff · DirectorSince 2023
-
Grace Colon · DirectorSince 2023
-
Hannah Valantine · DirectorSince 2023
-
John Walter Hanna Jr. · Director · President and CEOSince 2024
-
Michael Goldberg · DirectorSince 2023
-
Peter Maag · DirectorSince 2023
-
Reginald Seeto · Director · See RemarksSince 2023
-
Richard Bryan Riggsbee · DirectorSince 2024
-
Suresh Gunasekaran · DirectorSince 2025
-
William A. Hagstrom · DirectorSince 2023
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 93
16.4% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of June 12, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.0%
Board connections
5 of this board's directors also sit on 8 other boards. 6 are in the same sector.
-
Kyverna Therapeutics Inc. Same sectorvia Fred E. Cohen and Peter Maag
-
BridgeBio Pharma Inc. Same sectorvia Hannah Valantine
-
Intellia Therapeutics Inc. Same sectorvia Fred E. Cohen
- via Hannah Valantine
-
Progyny Inc. Same sectorvia Fred E. Cohen
- via Christine Cournoyer
-
UroGen Pharma Ltd. Same sectorvia Fred E. Cohen
-
Voyager Therapeutics Inc. Same sectorvia Grace Colon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $18,087,891
- 33 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Novack Jeffrey Adam Officer (Secretary and General Counsel) | Shares withheld for tax | −1,505 | $78.56 | $118,233 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Option exercise | +52,422 | $29.43 | $1,542,779 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −28,256 | $76.55 | $2,162,954 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −12,380 | $77.42 | $958,440 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −6,897 | $78.59 | $542,018 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −7,415 | $79.49 | $589,384 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −3,403 | $80.38 | $273,527 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −2,710 | $81.40 | $220,605 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −300 | $82.08 | $24,623 |
| Nov 5, 2026 | Kennedy Keith Officer (CFO & COO) | Open-market sale | −600 | $83.60 | $50,160 |
| Nov 3, 2026 | Fred E. Cohen Director | Gift | −25,000 | — | — |
| Nov 1, 2026 | Novack Jeffrey Adam Officer (Secretary and General Counsel) | Shares withheld for tax | −2,873 | $85.88 | $246,733 |
| Oct 2, 2026 | Michael Goldberg Director | Grant or award | +588 | — | — |
| Oct 1, 2026 | Kennedy Keith Officer (CFO & COO) | Shares withheld for tax | −3,018 | $66.23 | $199,882 |
| Oct 1, 2026 | John Walter Hanna Jr. Director, Officer (President and CEO) | Shares withheld for tax | −8,511 | $66.23 | $563,684 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about CareDx Inc.
Who is the CEO of CareDx Inc.?
John Walter Hanna Jr. has been CareDx Inc.'s President & CEO since April 2024.
How many directors are on CareDx Inc.'s board?
CareDx Inc.'s board has 13 directors: Arthur A. Torres, Christine Cournoyer, Fred E. Cohen, George Bickerstaff, Grace Colon, Hannah Valantine, John Walter Hanna Jr., Michael Goldberg, Peter Maag, Reginald Seeto and 3 others.
Are CareDx Inc. insiders buying or selling shares?
Over the last 12 months, CareDx Inc. insiders made no open-market purchases and sold $18.1 million of shares in 33 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="caredx-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.